Lupus is one of those autoimmune diseases that can cause us a lot of trouble. It makes the body attack itself, which can result in serious complications to the major organs and even death.
While there was known to be no cure for those suffering from lupus, these people can still live an acceptable life if the treatment starts early. But the situation might soon change if new research turns out to achieve its goal, as lupus patients might be treated with a simple pill.
Lupus pill shows promising results in mice
According to NeuroScienceNews.com, scientists came up with the new Afimetoran pill that aims to treat lupus, and it’s already showing promising results during its testing on mice. Not only that the medication was able to prevent the lupus symptoms in the little rodents, but it has even shown to be capable of reversing signs of organ damage and preventing death.
Alaric Dyckman, Ph.D, said as the same publication mentioned above quotes:
Few new therapies have succeeded, but we believe our compound could be an effective treatment for lupus.
He also added, as the same source quotes:
Genetic data and evaluations of injectable treatments suggested TLR7 and 8 could be drug targets for lupus. What was missing was an ability to directly block these receptors with small molecules that could be taken orally.
The most common type of lupus is Systemic lupus erythematosus (SLE). Lupus can affect the joints, lungs, brain, kidneys, skin, and blood vessels.
Ninety percent of lupus patients are women. The disease usually develops in a person between the ages of 15 and 44 years old.
The new results are awaited to be presented at the American Chemical Society (ACS).
The new pill is currently going through phase 2 clinical trials, so stay tuned for more news on the subject!